- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07947030
Medical Student Acceptance and Perceptions of Augmented Reality Simulation
Medical Student Acceptance and Perceptions of Augmented Reality Simulation: A Mixed-Methods, Prospective Study
This prospective, single-arm, mixed-methods pilot study will evaluate medical students' experiences with, perceptions of, and acceptance of augmented reality (AR) simulation. Medical students completing their core critical care medicine (CCM) clerkship at Stanford University will take part in a single 70-minute augmented reality (AR) simulation session at the Center for Immersive and Simulation-based Learning (CISL).
The session includes one instructor-facilitated pediatric intensive care unit (PICU) scenario using an AR headset. The primary outcome is students' experiences and perceptions, explored through thematic analysis of post-simulation focus groups. Secondary outcomes are technology acceptance (Technology Acceptance Model), usability (System Usability Scale), and ergonomics (ISO 9241-400-based questionnaire).
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Thomas Caruso, MD, PhD
- Numero di telefono: (650) 723-5728
- Email: tjcaruso@stanford.edu
Backup dei contatti dello studio
- Nome: ManYee Suen, MMedSc
- Numero di telefono: (650) 723-5728
- Email: smy822@stanford.edu
Luoghi di studio
-
-
California
-
Palo Alto, California, Stati Uniti, 94305
- Stanford University
-
Contatto:
- Thomas Caruso, MD, PhD
- Numero di telefono: (650) 723-5728
- Email: tjcaruso@stanford.edu
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Between age 18-50
- medical student participate in core critical care medicine (CCM) clerkship
Exclusion Criteria:
- a history of severe motion sickness
- a history of seizures cause by flashing light
- Major surgery within the last 48 hours
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Altro
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Augmented Reality (AR) Simulation
Medical students on their required core critical care medicine (CCM) clerkship take part in one instructor-facilitated pediatric critical care (PICU) simulation using an augmented reality headset. The scenario covers recognizing and managing a clinically deteriorating patient. After the session, participants complete the Technology Acceptance Model (TAM) questionnaire, the System Usability Scale (SUS) and an ergonomics questionnaire based on ISO 9241-400. They also join a semi-structured focus group about their experience, learning, teamwork, communication and tolerance of the AR technology. |
A single facilitated simulation session using an augmented reality headset [Quest 3]. It overlays a virtual pediatric patient and clinical findings onto the physical environment. Students work in small teams to assess the patient, recognize deterioration, prioritize actions, call for help, start management and reassess, using closed-loop communication. The session lasts about 4hours and is followed by a structured debrief. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
explore medical students' experiences with and perceptions of augmented reality (AR) simulation
Lasso di tempo: Immediately after intervention
|
Experiences and perceptions will be assessed through in-person, semi-structured focus group held at the end of the simulation session and led by a trained facilitator using a focus group guide. The guide contains six core questions plus probing prompts assessing attitudes, opinions, and perceptions of the intervention experience. Each focus group will last about 30 minutes and will be audio-recorded, transcribed, and de-identified. |
Immediately after intervention
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Technology acceptance
Lasso di tempo: immediately after the intervention
|
Technology acceptance will be assessed using an adapted Technology Acceptance Model (TAM) questionnaire immediately after the Augmented Reality simulation session. TAM contains 34 items rating on a 5-point Likert scale from 1 = strongly disagree to 5 = strongly agree. The items cover eight constructs: perceived usefulness (5 items), perceived ease of use (5 items), perceived enjoyment (4 items), intention to use (4 items), curiosity (4 items), social influence (4 items), facilitating conditions (4 items), and habit (4 items). where higher scores mean stronger agreement with that construct. |
immediately after the intervention
|
|
System Usability
Lasso di tempo: immediately after the intervention
|
Usability will be assessed using the System Usability Scale immediately after the Augmented Reality simulation session, rating each of the 10 items on a 5-point Likert scale from 1 = strongly disagree to 5 = strongly agree. Scores will be calculated using the standard SUS method: for odd-numbered items, 1 will be subtracted from the response; for even-numbered items, the response will be subtracted from 5. The adjusted item scores will be summed and multiplied by 2.5 to produce a total score from 0 to 100. |
immediately after the intervention
|
|
Ergonomics
Lasso di tempo: immediately after the intervention
|
Ergonomics will be assessed post-intervention using the ISO 9241-400. ISO 9241-400 contains 6-item with a scale from 1- 5, 1 being strongly disagree to 5 being strongly agree. |
immediately after the intervention
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
- 89744
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .